H.R. 2623 · 117th Congress
Cameron’s Law
- Stage
- In committee
- Sponsor
- Josh Gottheimer
- Introduced
- 2021-04-16
- Latest action
- 2021-04-19 · Referred to the Subcommittee on Health.
Summary
Cameron's Law
This bill increases the rate of the tax credit for clinical testing expenses for rare diseases or conditions from 25% to 50% (orphan drug tax credit).
The bill also requires the Centers for Disease Control and Prevention to complete a study to evaluate the feasibility of enhancing and expanding the infrastructure to track the epidemiology of rare diseases or conditions.